Eagle Genomics Seeks $1.6M to Launch Cloud-based Analysis Software | GenomeWeb

NEW YORK (GenomeWeb News) – Bioinformatics services and consulting company Eagle Genomics plans to raise £1 million ($1.6 million) in new financing to support commercialization of its new cloud-based life sciences data analysis product and expansion of its staff.

Eagle Genomics CEO David Flanders told GenomeWeb Daily News today that the four-and a-half year-old firm, based at the Babraham Research Campus in Cambridge, UK, is looking to raise the equity from venture capital and angel investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.